The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
Rattachement africain : gb, au, be, de, ie, es, us, it, in, se, nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic. METHODS: An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses. RESULTS: Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession. CONCLUSION: Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
- Date Crossref
- 01/02/2022
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
The Francis Crick Institute pays non établi dans la noticeStructure de recherche
-
The Christie NHS Foundation Trust Department of Medical Oncology pays non établi dans la noticeOrganisme public
-
Imperial College London Department of Medical Oncology pays non établi dans la noticeUniversité ou école supérieure
-
Royal Children's Hospital pays non établi dans la noticeÉtablissement de santé
-
Victorian Clinical Genetics Services pays non établi dans la noticeStructure de recherche
-
Murdoch Children's Research Institute pays non établi dans la noticeOrganisation à but non lucratif
-
Lancaster University pays non établi dans la noticeUniversité ou école supérieure
-
KU Leuven pays non établi dans la noticeUniversité ou école supérieure
-
Universität Hamburg pays non établi dans la noticeUniversité ou école supérieure
-
University Medical Center Hamburg-Eppendorf Department of Oncology pays non établi dans la noticeÉtablissement de santé
-
University Cancer Center Hamburg pays non établi dans la noticeÉtablissement de santé
-
University Hospital Waterford Department of Internal Medicine III pays non établi dans la noticeÉtablissement de santé
The Francis Crick Institute, Department of Medical Oncology — The Christie NHS Foundation Trust et Department of Medical Oncology — Imperial College London, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.